EMCC European Monitoring Centre on Change

Abbott Laboratories

Company/Organisation:
Abbott Laboratories

Geographic Location

Country: World
Location of affected unit(s): Within Europe, plants in Germany and the Netherlands are affected. Infomation on plants in other European countries wll follow.

Company

Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 93000

Employment Effects

Announcement Date: 21-09-2010
Planned Job Reductions min: 3000
Type of Restructuring: Internal restructuring
Foreseen End Date: 30-09-2012

Additional Information

The pharmaceutical company Abbott Laboratories intends to reduce its global workforce by 3,000, with most of the jobs losses due to take place across Europe. The company has already announced 500 job losses at its factory in Weesp (Netherlands) and 300 jobs in Hannover (Germany) with more European job reductions yet to be announced.

Most of the jobs losses will occur in the units previously owned by the pharmaceutical division of Solvay, acquired by Abbott. Following this take-over Abbott is now streamlining its operations and this includes job reductions in divisions such as marketing, R&D, sales and production.

The restructuring plan includes the closure of a Solvay facility in Marietta, Georgia (USA), by the end of 2011, Ms. Brotz said.

In addition, the work force at Solvay sites in Hannover, Germany, and Weesp, the Netherlands, will be scaled back.